A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer
Conditions
- Metastatic Castration Resistant Prostate Cancer
Interventions
- DRUG: Cabazitaxel
- DRUG: weekly cabazitaxel
Sponsor
Jeffrey Yachnin M.D., PhD.
Collaborators